Bioactive Compounds in Neurodegenerative Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Bioactives and Nutraceuticals".
Deadline for manuscript submissions: 20 November 2025 | Viewed by 837
Special Issue Editor
Interests: bioactive compounds; antioxidant state; vascular damage; neurotoxicity
Special Issue Information
Dear Colleagues,
Neurodegenerative diseases are a group of progressive conditions that affect the nervous system, leading to the gradual deterioration and death of neurons. These diseases, which include Alzheimer's, Parkinson's, Huntington's, and amyotrophic lateral sclerosis (ALS), among others, are characterized by various pathological hallmarks such as the accumulation of misfolded proteins, neuroinflammation, and oxidative stress.
Bioactive compounds have emerged as potential therapeutic agents in the context of neurodegenerative diseases. These molecules can modulate various cellular pathways and targets associated with disease pathology. They are known to play roles in suppressing inflammation, regulating gene expression, maintaining cellular membrane fluidity, and supporting immune functionality.
This Special Issue aims to uncover the role of bioactive molecules in treatment strategies in neurodegenerative diseases, as well as their potential to mitigate neuroinflammation, oxidative stress, and neuronal loss. Original and review articles, including basic studies, are all welcome to be submitted.
Dr. Silvia Lima Costa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioactive compounds
- neurodegenerative diseases
- neuroinflammation
- oxidative stress
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
